NCT06767683 - A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia | Biotech Hunter

Enrollment

256

Participants

Timeline

Start Date

January 27, 2025

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions

Narcolepsy Type 1Narcolepsy Type 2Idiopathic Hypersomnia

Interventions

DRUG

ALKS 2680, 4mg

Oral tablet containing 4 mg of ALKS 2680 for once daily administration

DRUG

ALKS 2680, 6mg

Oral tablet containing 6 mg of ALKS 2680 for once daily administration

DRUG

ALKS 2680, 8mg

Oral tablet containing 8 mg of ALKS 2680 for once daily administration

DRUG

ALKS 2680, 10mg

Oral tablet containing 10 mg of ALKS 2680 for once daily administration

DRUG

ALKS 2680, 14mg

Oral tablet containing 14 mg of ALKS 2680 for once daily administration

DRUG

ALKS 2680, 18mg

Oral tablet containing 18 mg of ALKS 2680 for once daily administration

Trial Locations (44)

2113

RECRUITING

Alkermes Investigational Site, Sydney

3570

RECRUITING

Alkermes Investigational Site, Alken

5042

RECRUITING

Alkermes Investigational Site, Bedford Park

5101

RECRUITING

Alkermes Investigational Site, Namur

8000

RECRUITING

Alkermes Investigational Site, Bruges

8025

RECRUITING

Alkermes Investigational Site, Zwolle

19001

RECRUITING

Alkermes Investigational Site, Abington

19610

RECRUITING

Alkermes Investigational Site, Wyomissing

20127

RECRUITING

Alkermes Investigational Site, Milan

28036

RECRUITING

Alkermes Investigational Site, Madrid

28037

RECRUITING

Alkermes Investigational Site, Denver

28043

RECRUITING

Alkermes Investigational Site, Madrid

28708

RECRUITING

Alkermes Investigational Site, Huntersville

29201

RECRUITING

Alkermes Investigational Site, Columbia

30281

RECRUITING

Alkermes Investigational Site, Stockbridge

30328

RECRUITING

Alkermes Investigational Site, Atlanta

31210

RECRUITING

Alkermes Investigational Site, Macon

32789

RECRUITING

Alkermes Investigational Site, Winter Park

33000

RECRUITING

Alkermes Investigational Site, Bordeaux

33176

RECRUITING

Alkermes Investigational Site, Miami

33511

RECRUITING

Alkermes Investigational Site, Brandon

34295

RECRUITING

Alkermes Investigational Site, Montpellier

37134

RECRUITING

Alkermes Investigational Site, Verona

40139

RECRUITING

Alkermes Investigational Site, Bologna

43017

RECRUITING

Alkermes Investigational Site, Dublin

44718

RECRUITING

Alkermes Investigational Site, Canton

45212

RECRUITING

Alkermes Investigational Site, Cincinnati

45245

RECRUITING

Alkermes Investigational Site, Cincinnati

48314

RECRUITING

Alkermes Investigational Site, Sterling Heights

48911

RECRUITING

Alkermes Investigational Site, Lansing

61637

RECRUITING

Alkermes Investigational Site, Peoria

68506

RECRUITING

Alkermes Investigational Site, Lincoln

72211

RECRUITING

Alkermes Investigational Site, Little Rock

77478

RECRUITING

Alkermes Investigational Site, Sugar Land

78229

RECRUITING

Alkermes Investigational Site, San Antonio

78731

RECRUITING

Alkermes Investigational Site, Austin

80918

RECRUITING

Alkermes Investigational Site, Colorado Springs

85054

RECRUITING

Alkermes Investigator Site, Phoenix

90025

RECRUITING

Alkermes Investigational Site, Los Angeles

94158

RECRUITING

Alkermes Investigator Site, San Francisco

94305

RECRUITING

Alkermes Investigational Site, Stanford

08036

RECRUITING

Alkermes Investigational Site, Barcelona

07748

RECRUITING

Alkermes Investigational Site, Middletown

128 21

RECRUITING

Alkermes Investigational Site, Prague